Treatment strategies for non-responders to oral iron and folic acid treatment in anemic children: A systematic review
Open Access
- 13 March 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (3) , e0003870
Abstract
Background Iron and folic acid (IFA) are essential nutrients, with deficiencies associated not only with anemia but also with other significant health consequences, including impaired cognitive development, increased susceptibility to infections, and adverse pregnancy outcomes. Despite the widespread use of IFA for management, a notable percentage of individuals failed to respond resulting in persistent anemia. This systematic review investigates the management of non-responders to oral iron and folic acid (IFA) treatment, among children under five. Non-responders are anemic individuals who do not recover after the standard IFA treatment. A comprehensive search was conducted across multiple databases including Medline, Cochrane, Embase, and Google Scholar, covering the period from January 1, 2000, to May 31, 2024. From the initial search of 14,242 studies, we conducted title and abstract screening, and 27 articles were selected for full text screening. After further exclusion, a total of 8 studies were identified, including randomized controlled trials, cohort studies, and case series. The review found that intravenous management, particularly ferric carboxymaltose, was found to be effective in cases of iron non-responsiveness. However, the causes of poor/non-responders to oral iron are less explored, indicating a need for further research. The review also identified a lack of high-quality studies on this topic. The review highlights the limited evidence on managing anemia unresponsive to oral iron, especially in low- and middle-income countries. While intravenous iron shows promise, more data is required to draw solid conclusions. Developing personalized treatment strategies is crucial to improving outcomes and addressing the global burden of anemia.Keywords
Funding Information
- Indian Council of Medical Research (Extramural Fund under grant number 5/7/594/1/-RHN)
This publication has 14 references indexed in Scilit:
- Iron deficiencyThe Lancet, 2021
- Intravenous ferric carboxymaltose for iron deficiency anemia or iron deficiency without anemia after poor response to oral iron treatment: Benefits and risks in a cohort of 144 children and adolescentsPediatric Blood & Cancer, 2020
- Monitoring oral iron therapy in children with iron deficiency anemia: an observational, prospective, multicenter study of AIEOP patients (Associazione Italiana Emato-Oncologia Pediatrica)Annals of Hematology, 2020
- Intravenous Ferric Carboxymaltose in Children with Iron Deficiency Anemia Who Respond Poorly to Oral IronThe Journal of Pediatrics, 2017
- Efficacy and Safety of Intravenous Ferric Carboxymaltose in Children with Iron Deficiency Anemia Unresponsive to Oral Iron TherapyBlood, 2015
- Intravenous iron sucrose for children with iron deficiency anemia: a single institution studyWorld Journal of Pediatrics, 2015
- Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral ironPediatric Blood & Cancer, 2013
- Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapyPediatric Blood & Cancer, 2010
- BLOOD MANAGEMENT: Large‐dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trialTransfusion, 2009
- Causal Relationship of Helicobacter pylori With Iron-Deficiency Anemia or Failure of Iron Supplementation in ChildrenGastroenterology, 2008